An Introduction to COVID-19
On 11 March 2020, the World Health Organization declared COVID-19 a pandemic. The impact on the medical community has been huge, not only on the front-line, but also for patients navigating treatment for neurological conditions during this unprecedented situation.
The touchNEUROLOGY expert faculty have been sharing their experiences and advice during this challenging time through video interviews and short articles.
Our supporting partners do not constitute an endorsement of the content on this page.
Neurological Manifestations of SARS-CoV-2 Infection and the Role of Complement Activation
touchREVIEWS in Neurology. 2022;18(2):86-92 DOI: https://doi.org/10.17925/USN.2022.18.2.86
The coronavirus disease 2019 (COVID-19) pandemic has led to unprecedented illness and death among the global population. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection can range from mild upper respiratory symptoms that subside with no lasting effects to multiorgan system failure and death.1 It can also result in numerous neurological symptoms that are less well […]
Suman Kushwaha, MDS 2022: COVID-19 vaccine induced parkinsonism and cognitive dysfunction
Two cases of COVID-19 vaccination associated neurological symptoms were presented, with patients displaying parkinsonism and cognitive dysfunction. In this touchNEUROLOGY interview, we speak with Dr Suman Kushwaha (Institute of Human Behaviour and Allied Sciences (IHBAS), Dilshad Garden, Delhi, India) to discuss the neurological symptoms and investigations leading to the case report conclusions. The abstract entitled […]
Suman Kushwaha, MDS 2022: Neurological symptoms and COVID-19 vaccination
Neurological complications, such as peripheral neuropathy, have been associated with COVID-19 vaccination. In this touchNEUROLOGY interview, we speak with Dr Suman Kushwaha (Institute of Human Behavior and Allied Sciences (IHBAS), Dilshad Garden, Delhi, India) to discuss the neurological symptoms that have been observed. The abstract entitled ‘Covid vaccine induced parkinsonism and cognitive dysfunction’ was presented […]
Raquel Gil-Gouveia, EAN 2022: Highlights in headache and migraine – Treatment advances, strategies for prevention, Anti-CGRP use in migraine, COVID-19
Headache is one of the most common nervous system disorders. In an interview with touchNEUROLOGY, Dr Raquel Gil-Gouveia (Hospital da Luz, Lisbon, Portugal) summarizes the ePoster session she chaired at EAN 2022, ranging from topics such as how COVID-19 has impacted on young people with headaches, the potential of new treatments such as eptinezumab and […]
Davide Martino, AAN 2022: Functional neurological symptoms in the time of COVID-19 – Learning from tic-like behaviours
Functional neurological symptoms have been observed in young people globally during the COVID-19 pandemic, presenting with rapid onset of complex motor and vocal tic-like behaviours. Dr Davide Martino (Hotchkiss Brain Institute, University of Calgary, Calgary, Canada) discusses the rise in tic-like behaviour during the COVID-19 pandemic and what registry studies taught us about interventions of […]
Gabriel A de Erausquin, AAIC 2021: The Alzheimer’s Association-led Global SARS-CoV-2 Consortium
touchNEUROLOGY joins Gabriel de Erausquin (UT Health San Antonio, TX, USA) at AAIC 2021 to discuss the Alzheimer’s Association-led Global SARS-CoV-2 Consortium and the links between long-term cognitive dysfunction, acceleration of Alzheimer’s symptoms and COVID-19. Questions Could you tell us a little about the Alzheimer’s Association-led global SARS-CoV-2 consortium? (00:30-02:07) What were the aims and […]
Munro Cullum, AAIC 2021: Telehealth-based Assessment of Cognition in Older Adults
touchNEUROLOGY joins Prof Munro Cullum (UT Southwestern Medical Center, Dallas, TX, USA) at AAIC 2021 to discuss the challenges faced during the COVID-19 pandemic and the impact of telehealth on clinical practice. Questions 1. What challenges to dementia research have been posed by the COVID-19 pandemic and how have telehealth procedures helped to overcome these? […]
What is the new normal for the treatment of multiple sclerosis in the age of COVID-19?
A panel of internationally renowned experts provide an update on MS treatment and assessment practices in the context of COVID-19. For subtitles in French, German, Italian, Russian and Spanish, please click [CC] on the video player below.
- Describe the COVID-19 symptom profiles in patients with multiple sclerosis
- Summarize the data describing how best to maintain use of disease-modifying therapies within the current pandemic
- Explain how to run a remote service under the restrictions of the current pandemic
Cerebral Venous Thrombosis and Delayed Awakening in a Young Adult with COVID-19: A Case Report
touchREVIEWS in Neurology. 2021;17(1):53-5 DOI: https://doi.org/10.17925/USN.2021.17.1.53
Healthcare workers are currently facing the coronavirus disease 2019 (COVID-19) pandemic and its complications, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Patients usually suffer from respiratory problems and non-specific neurological symptoms, such as headache, dizziness and ataxia, as well as specific neurological complications in some patients.1,2 Acute respiratory distress syndrome is a life-threatening […]
Journal articles and more to your inbox
Get the latest clinical insights from touchNEUROLOGYSign me up!